AGENO, WALTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.612
AS - Asia 14.194
EU - Europa 6.932
AF - Africa 3.535
SA - Sud America 3.447
Continente sconosciuto - Info sul continente non disponibili 727
OC - Oceania 356
Totale 44.803
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.245
SG - Singapore 3.256
CN - Cina 2.215
BR - Brasile 2.004
IT - Italia 1.742
VN - Vietnam 1.659
HK - Hong Kong 1.465
BD - Bangladesh 1.277
PL - Polonia 740
FR - Francia 632
CA - Canada 446
IN - India 370
AR - Argentina 319
NL - Olanda 302
JP - Giappone 247
TR - Turchia 238
IQ - Iraq 227
DE - Germania 215
MX - Messico 195
PK - Pakistan 187
ID - Indonesia 185
EC - Ecuador 184
SA - Arabia Saudita 183
RU - Federazione Russa 181
KR - Corea 170
PH - Filippine 166
ZA - Sudafrica 165
FI - Finlandia 163
CO - Colombia 154
GB - Regno Unito 147
UZ - Uzbekistan 140
MA - Marocco 136
VE - Venezuela 133
CL - Cile 132
HN - Honduras 131
PY - Paraguay 130
AL - Albania 127
JM - Giamaica 127
JO - Giordania 125
SE - Svezia 125
ES - Italia 122
AZ - Azerbaigian 119
EG - Egitto 119
LB - Libano 119
AO - Angola 114
GT - Guatemala 113
KE - Kenya 113
UA - Ucraina 113
UY - Uruguay 113
PS - Palestinian Territory 110
AE - Emirati Arabi Uniti 108
BJ - Benin 108
DO - Repubblica Dominicana 107
DZ - Algeria 107
PA - Panama 107
CR - Costa Rica 106
MY - Malesia 106
AT - Austria 105
CZ - Repubblica Ceca 105
DK - Danimarca 104
NI - Nicaragua 104
AM - Armenia 103
SN - Senegal 103
TH - Thailandia 101
ET - Etiopia 100
BA - Bosnia-Erzegovina 99
BE - Belgio 99
CW - ???statistics.table.value.countryCode.CW??? 99
IE - Irlanda 99
PT - Portogallo 99
RS - Serbia 98
BF - Burkina Faso 97
GA - Gabon 97
IL - Israele 97
KH - Cambogia 97
PE - Perù 97
TN - Tunisia 97
ML - Mali 96
RO - Romania 96
GR - Grecia 95
KZ - Kazakistan 95
UG - Uganda 95
BZ - Belize 94
ME - Montenegro 94
GF - Guiana Francese 93
NP - Nepal 92
PR - Porto Rico 92
TT - Trinidad e Tobago 92
ZW - Zimbabwe 92
CH - Svizzera 91
CI - Costa d'Avorio 91
LV - Lettonia 91
HU - Ungheria 90
AU - Australia 89
CV - Capo Verde 89
GE - Georgia 89
HR - Croazia 89
BO - Bolivia 88
LY - Libia 88
KG - Kirghizistan 87
Totale 39.997
Salva come PNG Salva come JPEG
Città #
San Jose 2.556
Singapore 1.782
Hong Kong 1.309
Ashburn 1.271
Santa Clara 919
Council Bluffs 730
Bytom 623
Los Angeles 610
Ho Chi Minh City 550
Lauterbourg 460
Hanoi 373
Chicago 349
New York 349
Hefei 328
Buffalo 218
Fairfield 212
Beijing 204
Milan 203
Dallas 201
Rome 185
Tokyo 167
Redondo Beach 161
São Paulo 153
Tashkent 121
Salt Lake City 120
Chandler 117
Amman 113
Baku 111
Houston 111
Nairobi 101
Managua 100
Seattle 100
Dakar 99
Cotonou 96
Baghdad 94
Kampala 93
Libreville 92
Bamako 90
Panama City 90
Phnom Penh 90
Woodbridge 90
Kingston 89
Montevideo 89
Seoul 89
Atlanta 88
Luanda 88
Orem 87
Cambridge 86
Abidjan 85
Da Nang 83
Haiphong 83
Ulan Bator 83
Yerevan 83
Harare 82
Toronto 82
Nassau 81
Nouakchott 80
Phoenix 80
San José 80
Munich 79
Wilmington 79
Castries 78
Kigali 78
Addis Ababa 77
Podgorica 77
Vienna 76
Vientiane 76
Ouagadougou 74
Bishkek 73
Lusaka 73
Naples 73
Willemstad 73
Bridgetown 71
Denver 71
Guatemala City 71
Helsinki 71
Tirana 71
Dushanbe 70
Cayenne 68
Guangzhou 68
Riga 68
Conakry 67
San Francisco 67
Accra 66
Antananarivo 66
Kingstown 66
Praia 66
Tbilisi 66
Andorra la Vella 65
Dili 64
Lahore 64
Noumea 64
Jeddah 63
Dublin 62
Guayaquil 61
Lima 61
Istanbul 60
Minsk 60
Montreal 60
Brooklyn 59
Totale 20.081
Salva come PNG Salva come JPEG
Nome #
How to treat isolated distal deep vein thrombosis 1.030
Cilostazol for peripheral arterial disease - a position paper from the Italian Society for Angiology and Vascular Medicine 390
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 380
Heparin in COVID-19 Patients Is Associated with Reduced In-Hospital Mortality: the Multicenter Italian CORIST Study 343
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study 283
Common cardiovascular risk factors and in-hospital mortality in 3,894 patients with COVID-19: survival analysis and machine learning-based findings from the multicentre Italian CORIST Study 279
Long-term outcomes of patients with cerebral vein thrombosis: A multicenter study 268
Disentangling the association of hydroxychloroquine treatment with mortality in covid-19 hospitalized patients through hierarchical clustering 263
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism 259
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation: The ARAPACIS Study 250
Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study 250
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study 249
Breadth of complications of long-term oral anticoagulant care 236
The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2 231
The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism 225
Inappropriate Underdosing of Direct Oral Anticoagulants in Atrial Fibrillation Patients: Results from the START2-AF Registry 223
RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies 221
Facts and Misfacts on D-Dimer Testing. Consensus Guidance From the Italian Society on Thrombosis and Hemostasis (SISET) 214
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 208
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 199
2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism 195
Portal Vein Thrombosis: State-of-the-Art Review 188
Can the Charlson comorbidity index help to guide DOAC dosing in patients with atrial fibrillation and improve the efficacy and safety of treatment? A subanalysis of the MAS study 186
Risk of Coronary Artery Disease in Patients with Liver Cirrhosis: A Systematic Review and Meta-analysis 183
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 183
The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial 180
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review 180
Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation 177
Association between the metabolic syndrome, its individual components, and unprovoked venous thromboembolism: results of a patient-level meta-analysis. 177
Description of the clinical and radiological characteristics of pulmonary embolism in COVID-19 vs non–COVID-19 patients: a multicentric cross-sectional study over a 24-month perspective 172
Direct Oral Anticoagulants for Pulmonary Embolism 170
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs 170
High-Sensitivity Cardiac Troponin T and the Diagnosis of Cardiovascular Disease in the Emergency Room: The Importance of Combining Cardiovascular Biomarkers with Clinical Data 166
Incidence and outcomes of splanchnic vein thrombosis after diagnosis of COVID-19 or COVID-19 vaccination: a systematic review and meta-analysis 165
Catheter-related deep vein thrombosis: Where are we at and where are we going? Updates and ongoing unmet clinical needs 163
D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results 161
Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis 159
Rivaroxaban treatment for six weeks versus three months in patients with symptomatic isolated distal deep vein thrombosis: Randomised controlled trial 157
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: Clinical characteristics, antibody profiles and estimate of the risk of recurrence 157
Lack of efficacy of direct oral anticoagulants compared to warfarin in antiphospholipid antibody syndrome 155
Management of Antithrombotic Therapy in Left Ventricular Thrombus: A Position Paper of the Italian Society of Hemostasis and Thrombosis (SISET) 151
Anticoagulation and compression therapy for proximal acute deep vein thrombosis 151
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 148
Measuring the crowding of emergency departments: an assessment of the NEDOCS in Lombardy, Italy, and the development of a new objective indicator based on the waiting time for the first clinical assessment 148
Incidence rates and case-fatality rates of cerebral vein thrombosis: A population-based study 147
Safety and efficacy of anticoagulant treatment in patients with ovarian vein thrombosis: a systematic review and meta-analysis of observational studies 146
Early Time Courses of Recurrent Venous Thromboembolism and Bleeding during Apixaban or Dalteparin Therapy for Patients with Cancer 144
Treatment of Superficial Vein Thrombosis: Recent Advances, Unmet Needs and Future Directions 143
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 142
Hypoalbuminaemia and heart failure: A practical review of current evidence 141
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature 141
PROPOSAL FOR THE INCLUSION OF LOW MOLECULAR WEIGHT HEPARINS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS IN THE WHO MODEL LIST OF ESSENTIAL MEDICINES 139
Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and peripheral vascular diseases and the ESC Working Group on pulmonary circulation and right ventricular function 138
Splanchnic vein thrombosis (2003−2022): a Swiss nationwide epidemiological study 135
Risk assessment tools for bleeding in patients with unprovoked venous thromboembolism: an analysis of the PLATO-VTE study 133
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants 133
Six-week low-molecular-weight heparin versus 12-week warfarin for calf deep vein thrombosis: A randomized, prospective, open-label study 133
Low in-hospital mortality rate in patients with COVID-19 receiving thromboprophylaxis: data from the multicentre observational START-COVID Register 132
Portal vein thrombosis in decompensated cirrhosis: rationale for treatment 132
Risk Factors for Intracerebral Hemorrhage in Patients with Atrial Fibrillation on Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention 131
Ultrasound elastography is useful to distinguish acute and chronic deep vein thrombosis 130
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis 129
Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000–18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database 129
Current Antithrombotic Prescribing Habits for Extended Secondary Prevention in Patients with Peripheral Artery Disease and Unprovoked Venous Thromboembolism: A Survey Among Specialists in Angiology and Vascular Surgery 128
In vitro effects of Apixaban on 5 different cancer cell lines 127
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 127
Guidelines and guidance: what is the path forward for the ISTH? 124
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 122
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study 121
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs 120
The Diagnostic Role of Lung Ultrasound and Contrast-Enhanced Ultrasound in Pulmonary Embolism 119
Incidence of chronic thromboembolic pulmonary hypertention after a first episode of pulmonary embolism 119
D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-Vitamin K anticoagulants 119
External validation of the DASH prediction rule: a retrospective cohort study 119
Venous thromboembolism in Asia and worldwide: Emerging insights from GARFIELD-VTE 118
Anticoagulant treatment for isolated distal deep vein thrombosis: a systematic review and meta-analysis 117
The Khorana score for prediction of venous thromboembolism in cancer patients: An individual patient data meta-analysis 117
ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism 116
Anticoagulation in Patients with Isolated Distal Deep Vein Thrombosis: Bringing the Puzzle Together 116
Cardiac power output is associated with cardiovascular related mortality in the ICU in post-cardiac arrest patients 116
Survival and Quality of Life after Early Discharge in Low-Risk Pulmonary Embolism 116
Reperfusion therapies in patients with acute ischaemic stroke and atrial fibrillation: data on safety and effectiveness from a multi-centre cohort study 115
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study 115
Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer 115
The metabolic syndrome and the risk of venous thrombosis: A case-control study 115
Management and Outcomes of Isolated Distal Deep Vein Thromboses: A Questionable Trend toward Long-Lasting Anticoagulation Treatment. Results from the START-Register 115
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy 113
A Practical Clinical Approach to Navigate Pulmonary Embolism Management: A Primer and Narrative Review of the Evolving Landscape 113
Current diagnostic and therapeutic approaches for peripheral arterial disease in Italy: a survey among vascular specialists of the Italian society of angiology and vascular medicine (SIAPAV) and general practitioners of the Italian federation of general practitioners (FIMMG) 113
Novel horizons in anticoagulation: the emerging role of factor XI inhibitors across different settings 113
Anticoagulant treatment for pediatric splanchnic vein thrombosis: a systematic review and meta-analysis 112
Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study 111
Factor XI/XIa inhibitors for splanchnic vein thrombosis associated with liver cirrhosis: Is there any potential role? 111
Pharmacotherapeutic management of venous thromboembolism during pregnancy and cesarean section 110
Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study 110
XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America 110
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism 110
Chronobiologic Aspects of Venous Thromboembolism 109
Common Practice in the Treatment of Superficial Vein Thrombosis Involving the Sapheno-Femoral Junction: Results from a National Survey of the Italian Society of Angiology and Vascular Medicine (SIAPAV) 109
Algorithm for rapid exclusion of clinically relevant plasma levels of DOACs in patients using the DOAC Dipstick. An expert consensus paper 109
Totale 16.930
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.924
article - articoli 92.991
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 265
patent - brevetti 0
selected - selezionate 0
volume - volumi 468
Totale 188.648
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022307 0 0 60 26 32 18 15 25 41 9 23 58
2022/2023186 39 28 4 21 25 16 2 18 13 1 19 0
2023/2024182 3 13 15 11 16 40 17 36 7 2 15 7
2024/20254.070 7 50 54 31 51 46 45 45 64 647 1.175 1.855
2025/202634.087 711 1.997 7.075 7.402 1.871 1.241 2.198 2.897 2.872 1.454 2.064 2.305
2026/20275.406 2.863 2.272 271 0 0 0 0 0 0 0 0 0
Totale 44.803